SFXN3 expression levels in CHOL, HNSC, KIRC, acute myeloid leukemia (LAML), PAAD, PCPG, and sarcoma (SARC) were upregulated compared with those in the corresponding normal controls in the GEPIA database (all p < 0.05, Figure S1B). This evidence concerns the gene SFXN3 and pancreatic adenocarcinoma.